Copied
 
 
Formål
Formål
Selskabets formål er markedsføring og salg af diagnostiske instrumenter og ydelser til kliniske laboratorier, sygehuse, læger, m.v., samt al virksomhed som efter bestyrelsens skøn er beslægtet her med.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 06.05.2014 (3649 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 27.01.2005 (7035 dage).
Ingen historik.
Branche
Branche
Engroshandel med medicinalvarer og sygeplejeartikler (464610).
Sidst opdateret den 24.12.2007 og angivet som gældende fra 01.01.2008 (5966 dage).
HistorikStartStop
Engroshandel med medicinalvarer og sygeplejeartikler (464610)01.01.2008
Engroshandel med medicinalvarer og sygeplejeartikler (514610)31.03.200531.12.2007
Uoplyst (980000)27.01.200530.03.2005
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 27.01.2005 (7035 dage).
Ingen historik.
Revisor
Revisor
KPMG P/S
Sidst opdateret den 09.02.2015 og angivet som gældende fra 06.05.2014 (3649 dage).
HistorikStartStop
KPMG P/S06.05.2014
EY Godkendt Revisionspartnerselskab09.05.200806.05.2014
CJ Partnership I/S27.01.200509.05.2008
Form
Virksomhedsform
60.
Sidst opdateret den 28.02.2005 og angivet som gældende fra 27.01.2005 (7035 dage).
Ingen historik.
Kontakt
Ingen nuværende registrering.
Ingen historik.
Telefon
Ingen nuværende registrering.
Ingen historik.
Navne
Ingen historik.
Binavne
Binavne
OBI A/S.
Sidst opdateret den 08.03.2024 og angivet som gældende fra 08.03.2024 (55 dage).
Ingen historik.
Tegningsregel
Tegningsregel
Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem og en direktør i forening eller af den samlede bestyrelse.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 06.05.2014 (3649 dage).
Fortolkning (3 tegningsmuligheder)
2 bestyrelsesmedlemmer +
1 bestyrelsesmedlem + 1 direktør
bestyrelsen
Ingen historik.
Ansatte
02.05.2024
Kapital
02.05.2024
Fra årsrapport
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:KPMGStatsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:State AuthorisedPublic Accountant
Virksomhedens regnskabsklasse:Reporting class C, large enterprise
Grundlag for konklusion (revision):Basis for opinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and theadditional requirements applicable in Denmark. Our responsibilities under those standards andrequirements are further described in the "Auditor's responsibilities for the audit of the financialstatements" section of our report. We are independent of the Company in accordance with the International Ethics StandardsBoard for Accountants' International Code of Ethics for Professional Accountants (IESBA Code)and the additional ethical requirements applicable in Denmark, and we have fulfilled our otherethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide abasis for our opinion.
Konklusion (revision):OpinionWe have audited the financial statements of Roche Diagnostics A/S for the financial year1 January – 31 December 2022 comprising income statement, balance sheet, statement ofchanges in equity and notes, including accounting policies. The financial statements areprepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Company's assets,liabilities and financial position at 31 December 2022 and of the results of the Company'soperations for the financial year 1 January – 31 December 2022 in accordance with the DanishFinancial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's reviewManagement is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do notexpress any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read theManagement's review and, in doing so, consider whether the Management's review is materiallyinconsistent with the financial statements or our knowledge obtained during the audit, orotherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides theinformation required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is inaccordance with the financial statements and has been prepared in accordance with therequirements of the Danish Financial Statement Act. We did not identify any materialmisstatement of the Management's review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
02.05.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
02.05.2024
Ingen nuværende registrering.
Ingen historik.